Evidence map›Paper›PMID 21887707›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2012

Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype.

Glovioell W Rowland, Gary G Schwartz, Esther M John, Sue Ann Ingles

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2016
    Pooled it
  4. Pooled it
  5. Dietary factors and risk for advanced prostate cancer.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2014
    Pooled it
  6. Article
  7. Review
  8. Calcium Activation of the Androgen Receptor in Prostate Cells.International journal of endocrinology · 2023
    Article
  9. Current urology · 2022
    Article
  10. Review
  11. Article
  12. PCaLiStDB: a lifestyle database for precision prevention of prostate cancer.Database : the journal of biological databases and curation · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Glovioell W RowlandDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
Gary G Schwartz
Esther M John
Sue Ann Ingles
University of Southern California · USCancer Prevention Institute of California · USWake Forest University · US

Funding

CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
Training Grant in Genomic Analysis and InterpretationT32ES013678 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAUDERMAN, WILLIAM JAMES, MCCONNELL, ROB S · 2006 to 2023
$5.6M
RISK FACTORS FOR ADVANCED PROSTATE CANCERR01CA084979 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI INGLES, SUE ANN · 1999 to 2003
$2.2M
NCCDPHP CDC HHS 1U58DP000807-3NCCDPHP CDC HHS U58 DP000807NCI NIH HHS N01 PC035136NCI NIH HHS N01 PC035139NCI NIH HHS N01-PC-35136NCI NIH HHS N01-PC-35139NCI NIH HHS R01 CA084979NCI NIH HHS R01CA84979NIEHS NIH HHS T32 ES013678NIEHS NIH HHS T32-ES013678
6 · The paper itself

Abstract

High dietary intake of calcium has been classified as a probable cause of prostate cancer, although the mechanism underlying the association between dietary calcium and prostate cancer risk is unclear. The vitamin D receptor (VDR) is a key regulator of calcium absorption. In the small intestine, VDR expression is regulated by the CDX-2 transcription factor, which binds a polymorphic site in the VDR gene promoter. We examined VDR Cdx2 genotype and calcium intake, assessed by a food frequency questionnaire, in 533 African-American prostate cancer cases (256 with advanced stage at diagnosis, 277 with localized stage) and 250 African-American controls who participated in the California Collaborative Prostate Cancer Study. We examined the effects of genotype, calcium intake, and diet-gene interactions by conditional logistic regression. Compared with men in the lowest quartile of calcium intake, men in the highest quartile had an approximately twofold increased risk of localized and advanced prostate cancer (odds ratio [OR] = 2.20, 95% confidence interval [CI] = 1.40, 3.46), with a significant dose-response. Poor absorbers of calcium (VDR Cdx2 GG genotype) had a significantly lower risk of advanced prostate cancer (OR = 0.41, 95% CI = 0.19, 0.90). The gene-calcium interaction was statistically significant (p = 0.03). Among men with calcium intake below the median (680 mg/day), carriers of the G allele had an approximately 50% decreased risk compared with men with the AA genotype. These findings suggest a link between prostate cancer risk and high intestinal absorption of calcium.

Indexed as

AgedAged, 80 and overBlack or African AmericanCalciumCalcium, DietaryCase-Control StudiesCDX2 Transcription FactorDietary SupplementsHomeodomain ProteinsHumansIntestinal AbsorptionMaleMiddle AgedObesityPolymorphism, GeneticProstatic NeoplasmsCalciumCalcium, DietaryCDX2 protein, humanCDX2 Transcription FactorHomeodomain ProteinsReceptors, CalcitriolVDR protein, human

Identifiers

PMID21887707
PMCPMC3234334
OpenAlexW2070913770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.